妊娠11-13周眼动脉多普勒预测子痫前期
前瞻性观察研究纳入4066例妊娠,114例(2.8%)发生子痫前期,其中25例(0.6%)在37周前分娩。眼动脉第二与第一收缩期峰值流速比值(PSV比值)在子痫前期中显著升高,且早产子痫前期的偏离大于足月子痫前期。模型显示在10%假阳性率下,PSV比值可提高早产子痫前期的检出率,但未改善足月子痫前期的预测。
要点
- 妊娠11-13周眼动脉PSV比值在子痫前期中显著升高,早产子痫前期偏离大于足月子痫前期。
- 在10%假阳性率下,PSV比值使早产子痫前期检出率从46.3%升至58.4%(仅母体因素)、从65.9%升至70.6%(母体因素+MAP+UtA-PI)、从74.6%升至76.7%(母体因素+MAP+UtA-PI+PlGF)。
- PSV比值未改善任何生物标志物组合对足月子痫前期的预测。
核心结论
- 妊娠11-13周眼动脉PSV比值可能是预测后续发生早产子痫前期的有用生物标志物,但需要更大规模的研究来验证这一发现。
研究设计与样本
- 前瞻性观察研究,纳入4066例在妊娠11+0至13+6周进行常规医院访视的孕妇,记录母体人口学特征和病史、胎儿解剖和生长超声、眼动脉血流速度波形并计算PSV比值、测量MAP和血清PAPP-A;另对发生子痫前期的病例和未受影响对照的储存样本进行病例对照研究以测量PlGF。
关键影像表现/征象
- 眼动脉PSV比值在子痫前期妊娠中显著升高,且其效应取决于分娩孕周,早产子痫前期的偏离大于足月子痫前期。
诊断标准与关键数值
- 在10%假阳性率下,仅母体危险因素对早产子痫前期的检出率为46.3%,加入PSV比值后升至58.4%。
- 在10%假阳性率下,母体因素+MAP+UtA-PI对早产子痫前期的检出率为65.9%,加入PSV比值后升至70.6%。
- 在10%假阳性率下,母体因素+MAP+UtA-PI+PlGF对早产子痫前期的检出率为74.6%,加入PSV比值后升至76.7%。
- PSV比值未改善任何生物标志物组合对足月子痫前期的预测。
局限性
- 需要更大规模的研究来验证这一发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To examine the potential value of maternal ophthalmic artery Doppler at 11-13 weeks' gestation, alone and in combination with the established first-trimester biomarkers of pre-eclampsia (PE), including uterine artery pulsatility index (UtA-PI), mean arterial pressure (MAP), serum placental growth factor (PlGF) and serum pregnancy-associated plasma protein-A (PAPP-A), in the prediction of subsequent development of PE.
METHODS: This was a prospective observational study in women attending for a routine hospital visit at 11 + 0 to 13 + 6 weeks' gestation. This visit included recording of maternal demographic characteristics and medical history, ultrasound examination for fetal anatomy and growth, assessment of flow velocity waveforms from the maternal ophthalmic arteries and calculation of the second-to-first peak systolic velocity (PSV) ratio, and measurement of MAP and serum PAPP-A. In addition, a case-control study was carried out for measurement of PlGF in stored samples from cases that developed PE and unaffected controls. The values of PSV ratio, UtA-PI, MAP, PAPP-A and PlGF were converted to multiples of the median or deltas to remove the effects of maternal characteristics and medical history. The competing-risks model was used to estimate the individual patient-specific risk of delivery with PE at < 37 and < 41 + 3 weeks' gestation for various combinations of markers. Performance was assessed using detection rates, at a fixed false-positive rate (FPR), and areas under the receiver-operating-characteristics curves. Modeled performance was also assessed.
RESULTS: The study population of 4066 pregnancies contained 114 (2.8%) that developed PE, including 25 (0.6%) that delivered with PE at < 37 weeks' gestation. The PSV ratio was significantly increased in PE pregnancies, and the effect of PE depended on gestational age at delivery, with the deviation from normal being greater for early than for late PE. Modeling demonstrated that the addition of PSV ratio improved the detection rate, at a 10% FPR, of preterm PE provided by maternal risk factors alone (from 46.3% to 58.4%), maternal factors, MAP and UtA-PI (65.9% to 70.6%), and maternal factors, MAP, UtA-PI and PlGF (74.6% to 76.7%). The PSV ratio did not improve the prediction of term PE provided by any combination of biomarkers.
CONCLUSION: Ophthalmic artery PSV ratio at 11-13 weeks' gestation is a potentially useful biomarker for prediction of subsequent development of preterm PE, but larger studies are needed to validate this finding. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Gana N, Sarno M, Vieira N, et al. Ophthalmic artery Doppler at 11-13 weeks' gestation in prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2022. PMID: 35642909. doi:10.1002/uog.24914
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。